Trump's pick to run the Department of Health and Human Services gave away the agenda -- and may have invited a strong legal ...
This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...